In genetics, “cis” and “trans” describe where two genetic elements sit relative to each other. Cis means on the same DNA molecule or chromosome; trans means on different ones. The distinction matters because a regulatory sequence sitting right next to a gene on the same strand of DNA controls that gene very differently than a protein encoded by a faraway gene on another chromosome would. These two words show up across nearly every corner of modern genetics, from gene regulation and RNA processing to evolutionary biology and disease research, and the specifics change depending on context.
Where the Terms Come From
The words themselves are borrowed from Latin and chemistry: cis means “on the same side,” trans means “across” or “on the other side.” They entered genetics formally in the 1950s, when Seymour Benzer and his colleagues developed what became known as the cis-trans test. Working with a virus that infects bacteria called bacteriophage T4, Benzer studied hundreds of mutations in a gene called rII. All of these mutations produced the same visible effect (oversized plaques on a bacterial lawn), but the cis-trans test revealed that the rII region was actually made up of two separate functional units, which Benzer named “cistrons.”1PubMed Central. Complementation and allelism: the cis-trans test The logic was straightforward: if you put two mutations on the same DNA molecule (the cis configuration), the other intact copy could compensate. But if you put one mutation on each of two different copies (the trans configuration), and the organism still functioned normally, the mutations had to be in different functional units. That functional unit, the cistron, is essentially what we now call a gene. The test itself has faded from everyday lab work, but the vocabulary it introduced stuck and expanded far beyond its original meaning.
Cis-Regulatory Elements
The most common use of “cis” in modern genetics refers to regulatory DNA sequences that control a nearby gene on the same chromosome. The classic examples are promoters and enhancers. A promoter sits right at the start of a gene and serves as the landing pad for the molecular machinery that reads the gene into RNA. An enhancer can sit thousands or even hundreds of thousands of base pairs away from the gene it controls, but the key point is that it is still on the same physical piece of DNA. The two are brought into contact when the intervening DNA loops around in three-dimensional space, allowing the enhancer to physically touch the gene’s promoter.2PubMed Central. Mechanisms of enhancer action: the known and the unknown
This looping is not random. The three-dimensional folding of chromosomes inside the nucleus is organized into neighborhoods called topologically associating domains, or TADs. These are stretches of DNA that interact with themselves much more frequently than with DNA outside their boundaries. Proteins like CTCF act as boundary markers that help maintain these neighborhoods. In the beta-globin gene cluster, for instance, multiple CTCF-binding sites cooperate to maintain a TAD that keeps the gene’s enhancers in close spatial proximity to its promoter. When researchers deleted several of these CTCF-binding sites, the TAD fell apart, enhancer-promoter contacts weakened, and gene output dropped, even though the enhancers themselves still bore the chemical marks of being active.3PubMed. Multiple CTCF sites cooperate with each other to maintain a TAD for enhancer-promoter interaction in the β-globin locus The enhancers were still “on,” but without the right spatial architecture to deliver their signal, the gene stayed quiet. This illustrates something important about cis regulation: physical proximity on the same molecule is necessary, but the three-dimensional packaging of that molecule matters enormously.
The boundaries of these chromosomal neighborhoods can also shift between cell types. In studies of the HoxA gene cluster, which helps determine body patterning during development, the insulation strength of CTCF-mediated boundaries differed between embryonic stem cells and motor neurons, even though CTCF itself was bound to the same sites in both cell types.4Genes & Development. CTCF-mediated topological boundaries during development foster appropriate gene regulation Other proteins, including those in the polycomb complex that help compact inactive chromatin, could override CTCF’s boundary function. The result is that cis-regulatory landscapes are not fixed blueprints; they are dynamic and context-dependent.
Trans-Acting Factors
Trans-acting factors are the mobile players. A gene on chromosome 6 might encode a protein that floats through the nucleus and lands on a regulatory region of a gene on chromosome 11, switching it on or off. Transcription factors are the most familiar example: proteins that bind specific short DNA sequences and recruit or block the machinery that reads genes into RNA. Because these proteins are produced from one location and then diffuse freely to act elsewhere, they are, by definition, acting in trans.
The distinction has a practical consequence that matters for inheritance. A cis-regulatory mutation affects only the copy of the gene it is physically attached to. If you have a mutation in an enhancer on one chromosome, only the gene on that same chromosome feels the effect; the copy on your other chromosome keeps humming along with its own intact enhancer. A trans-acting mutation, by contrast, can affect both copies of a target gene at once, because the mutant protein (or the lack of a normal one) reaches both chromosomes equally. This asymmetry shapes how genetic variation plays out in populations and in disease.
How Scientists Separate Cis from Trans Effects
Distinguishing cis from trans effects experimentally is one of the workhorses of modern genomics. One common approach uses expression quantitative trait loci, or eQTLs. These are spots in the genome where natural genetic variation between individuals correlates with differences in how much a nearby (or distant) gene is expressed. A cis-eQTL sits close to the gene it influences, typically within a megabase, and acts locally. A trans-eQTL sits far away, often on a different chromosome entirely, and usually works by altering a transcription factor or signaling molecule that then affects the distant target gene.
A large blood-based study detected cis-eQTLs for about 88% of genes tested, and these local effects replicated well across different tissues. Trans-eQTLs were found for roughly 37% of disease-associated variants examined, but they replicated less reliably, partly because their effects tend to be smaller and harder to detect, and partly because differences in cell-type composition across samples can create false signals.5PubMed Central. Large-scale cis- and trans-eQTL analyses identify thousands of genetic loci and polygenic scores that regulate blood gene expression When the researchers drilled into single-cell data to remove those confounders, they confirmed that many trans-eQTLs act through transcription factors, exactly as the cis/trans framework predicts.
Another approach uses hybrid organisms. Researchers cross two genetically distinct strains and then measure whether each parent’s version of a gene is expressed at the same level in the hybrid offspring. If one parent’s allele consistently produces more RNA than the other within the same cell, that imbalance must be driven by cis-regulatory differences, because both alleles are exposed to exactly the same pool of trans-acting factors. In a study of natural populations of fruit flies, cis-regulatory divergence was detected at about 70% of informative sites, and trans-regulatory divergence showed up at a similar rate of about 68%.6PubMed Central. RNA-seq analysis of allele-specific expression, hybrid effects, and regulatory divergence in hybrids compared with their parents from natural populations A comparable strategy has been applied in plants using hybrids of two wild strains of Arabidopsis.7Genetics. Global Analysis of Allele-Specific Expression in Arabidopsis thaliana
Cis and Trans in RNA Splicing
The cis/trans distinction does not stop at gene regulation. It extends into how RNA is processed after it is copied from DNA. Most genes in your genome contain stretches of sequence (introns) that need to be cut out so that the coding pieces (exons) can be stitched together into a mature messenger RNA. This standard splicing is a cis process: the splice donor and splice acceptor sites are on the same RNA molecule, separated by the intron, and the molecular machinery clips out the intervening sequence and joins the flanking exons.
Trans-splicing, by contrast, joins pieces from two separate RNA molecules. The best-studied version is spliced-leader trans-splicing, in which a short leader sequence from one small RNA is attached to the front end of a completely different pre-messenger RNA. In this process, the splice donor site comes from the leader RNA and the splice acceptor site sits on the target RNA, so the two reactive sequences that need to come together are on different molecules.8Cell Press (Current Biology). Spliced leader trans-splicing This is widespread in nematodes like C. elegans and in trypanosomes, and it plays a role in producing functional messenger RNAs from polycistronic gene clusters. It is rare in vertebrates, but researchers have documented it in certain contexts.
Even within conventional cis-splicing, the interplay between cis-acting and trans-acting elements is intricate. Cis-acting elements are the short sequence motifs within the RNA itself that tell the splicing machinery where to cut and paste. Trans-acting factors are the proteins, particularly the SR protein family, that recognize those motifs and either promote or suppress a particular splicing choice. A striking example involves a gene called U2af26 in mice, where daily temperature rhythms drive oscillating patterns of alternative splicing. The cis-acting enhancer elements within one exon, combined with the activity of trans-acting SR proteins SRSF2 and SRSF7, together produce daily rhythms in how the gene’s RNA is spliced. The direction of the splicing change depends on where the cis-acting elements sit within the RNA.9PubMed Central. Characterization of cis-acting elements that control oscillating alternative splicing
New long-read sequencing technologies are making it possible to sort out cis-directed versus trans-directed splicing events on a genome-wide scale. Because long reads can capture full-length RNA molecules, researchers can see which splicing choices travel together on the same molecule, revealing thousands of cis-directed splicing events that are susceptible to genetic variation between individuals.10PubMed Central. Long-read RNA-seq demarcates cis- and trans-directed alternative RNA splicing This kind of information is becoming increasingly relevant for understanding why the same mutation causes different symptoms in different people.
The Evolutionary Picture
Whether regulatory evolution happens mostly through cis or trans changes is a question that has occupied evolutionary geneticists for years. The current picture is nuanced. Studies in yeast and flies have found that trans-regulatory mutations are more common as raw material, meaning new mutations that change gene expression through trans effects arise more frequently than cis mutations do. But cis-regulatory mutations tend to have larger individual effects on how much a gene is expressed.11PubMed Central. Contrasting Frequencies and Effects of cis- and trans-Regulatory Mutations Affecting Gene Expression When you look only at the biggest expression changes, cis and trans contributions become roughly equal, because cis mutations punch above their weight.
Natural selection also treats the two categories differently. In yeast, researchers found that trans-regulatory variation is more constrained by selection in functionally important genes compared with less important ones, while cis-regulatory variation showed no such pattern.12Molecular Biology and Evolution. Inheritance of Gene Expression Level and Selective Constraints on Trans- and Cis-Regulatory Changes in Yeast One reason is that trans-acting factors like transcription factors typically regulate many genes at once, so a mutation that alters a transcription factor can cascade across dozens or hundreds of targets. That pleiotropic nature makes trans mutations more likely to be harmful and therefore more tightly policed by selection. Cis mutations, by contrast, generally affect only one gene, so they can be tweaked more freely without collateral damage. This makes cis changes a particularly fertile ground for adaptive evolution.
Consistent with this, a genome-wide analysis of human diploid genomes found that coding variants tend to sit in the cis configuration more often than in trans, with a global cis-to-trans ratio of roughly 60:40. This cis-abundance was observed across virtually all populations studied. The researchers identified a group of “cis-abundant” genes and a smaller group of “trans-abundant” genes, and the two categories turned out to be functionally distinct, with different patterns of protein-changing variation that appeared to reflect long-term evolutionary pressures related to adaptation.13Oxford Academic. Significant abundance of cis configurations of coding variants in diploid human genomes
Disease and Complex Traits
The cis/trans framework has direct implications for understanding human disease. Genome-wide association studies have repeatedly found that most genetic variants linked to disease risk sit outside the protein-coding parts of genes, in non-coding regions where cis-regulatory elements like enhancers reside. Fine-mapping of some of these associations has uncovered novel cis-acting regulatory elements located as far as 1.5 million base pairs from their target gene, involved in conditions ranging from diabetes and Crohn’s disease to colorectal cancer and asthma.14PubMed Central. Cis-regulatory mutations in human disease Because these regulatory mutations are physically tethered to the gene they influence, they often have tissue-specific effects. A mutation in a liver-specific enhancer might alter cholesterol metabolism without affecting the same gene’s function in the brain, for example.
Trans effects matter too, especially for complex traits where thousands of genetic variants each contribute a small amount. In cattle, where large datasets allow precise estimation, cis and trans regulatory variants detected across 16 tissues jointly explained about 69% of the heritable variation in 37 different traits, well above what the same number of random variants would explain. Of that total, trans regulatory variants accounted for roughly 24% of heritability on their own.15PubMed Central. Regulatory variants explain the majority of heritability in complex traits of cattle The fact that trans effects contribute so substantially is a reminder that the “master regulator” genes, transcription factors and signaling molecules that coordinate the activity of many other genes, are critical drivers of trait variation even if their individual effects on any one target gene are small.
Research on transcription factors involved in immune disorders underscores this point. Genes associated with inborn errors of immunity tend to have many outgoing regulatory connections, meaning they influence the expression of many downstream targets. These outgoing connections were more strongly associated with evolutionary constraint than incoming connections were, suggesting that the trans-regulatory hubs of the genome are under intense selective pressure because mutations in them ripple across entire regulatory networks.16Cell Genomics. Systematic discovery and perturbation of transcription factors in inborn errors of immunity identifies immunological networks
Transvection and Cross-Chromosome Conversations
One of the more surprising wrinkles in the cis/trans story comes from a phenomenon called transvection, best studied in the fruit fly Drosophila. In most organisms, your two copies of each chromosome (one from each parent) float around the nucleus independently. In Drosophila, though, homologous chromosomes physically pair up throughout development, and this pairing allows regulatory elements on one chromosome to influence the gene on the paired chromosome. During transvection, an enhancer on one allele can activate or repress the other allele sitting across from it on the paired homolog.17PubMed Central. Activating and repressing gene expression between chromosomes during stochastic fate specification
This blurs the boundary between cis and trans. The regulatory element is acting on a gene that is not on the same physical molecule of DNA, which would normally make it trans. But it only works because the two chromosomes are held in close physical proximity by the pairing machinery, mimicking a cis-like arrangement. Specific regions called “buttons” mediate this pairing, and pairing strength varies between cell types, which in turn regulates how efficiently transvection occurs.18PubMed Central. Characterization of Button Loci that Promote Homologous Chromosome Pairing and Cell-Type-Specific Interchromosomal Gene Regulation Transvection at the Malic enzyme locus in Drosophila, for instance, depends on chromosomal architecture: chromosomal inversions that disrupt pairing eliminate the trans-regulatory effect entirely. The phenomenon is also plastic, varying with both genetic background and environmental conditions.19PubMed Central. Transvection-based gene regulation in Drosophila is a complex and plastic trait
Transvection is not just a curiosity of fly biology. The principles of inter-chromosomal gene regulation show up in mammalian processes like X-chromosome inactivation and genomic imprinting, where one copy of a gene is silenced based on its parent of origin. These systems also rely on chromosomal proximity and physical contact between homologs at specific developmental windows. They stretch the traditional cis/trans definitions and remind us that the cell’s three-dimensional architecture makes the genome’s regulatory logic far messier than a simple same-molecule-versus-different-molecule classification might suggest.
Engineering Cis-Regulatory Elements With CRISPR
Understanding the cis/trans distinction is not just an intellectual exercise. It has become directly useful in biotechnology. One recent application is the use of CRISPR-based tools to edit enhancer function without cutting the DNA. Systems called enCRISPRa and enCRISPRi use a deactivated version of the Cas9 protein fused to enzymes that add or remove chemical marks on the histone proteins that package DNA. By targeting these tools to a specific enhancer, researchers can switch the enhancer on or off and watch the effect on the nearby gene.20PubMed Central. Interrogation of enhancer function by enhancer-targeting CRISPR epigenetic editing Because the system works by remodeling the local chromatin landscape at a particular cis-regulatory element, it provides a precise way to test whether a suspected enhancer really does control the gene next to it, both in cultured cells and in living organisms. This kind of tool is already being used to validate the cis-regulatory variants flagged by genome-wide association studies, connecting a statistical signal in a patient cohort to a concrete mechanism in a specific tissue.